Abstract
The methanol extract from Salvia miltiorrhiza Bungee showed a suppressive effect on umu gene expression of the SOS response in Salmonella typhimurium TA1535 / pSK1002 against the mutagen, Trp-P-1, which requires liver metabolizing enzyme. The methanol extract was successively re-extracted with dichloromethane, butanol, and water. Three suppressive compounds were isolated by SiO2 column chromatography from dichloromethane fraction and identified as tanshinone IIA (1), tanshinone I (2) and Cryptotanshinone (3) by GC, GC-MS, 1H- and 13C-NMR spectroscopy. Compounds 1, 2 and 3 inhibited the SOS-inducing activity of Trp-P-1 in the umu test. Gene expression was suppressed by 76%, 96% and 81% at less than 0.18 μmol / mL, 9 respectively. The ID50 (50% inhibition dose) values were 0.03 μmol / mL 0.008 μmol / mL and 0.010 μmol / mol, respectively. These compounds were assayed with activated Trp-P-1. Compound 2 showed suppressive effect of SOS-inducing activity of activated Trp-P-1 but compounds 1 and 3 did not.
Keywords: salvia miltiorrhiza bunge, diterpenoid, tanshinone, sos response, umu test, antimutagen
Letters in Drug Design & Discovery
Title: Suppressive Components in Salvia miltiorrhiza Against Trp-P-1 and Activated Trp-P-1-Induced SOS Response Using Salmonella typhimurium TA1535 / pSK1002 Umu Test
Volume: 1 Issue: 1
Author(s): Yoshiharu Okuno and Mitsuo Miyazawa
Affiliation:
Keywords: salvia miltiorrhiza bunge, diterpenoid, tanshinone, sos response, umu test, antimutagen
Abstract: The methanol extract from Salvia miltiorrhiza Bungee showed a suppressive effect on umu gene expression of the SOS response in Salmonella typhimurium TA1535 / pSK1002 against the mutagen, Trp-P-1, which requires liver metabolizing enzyme. The methanol extract was successively re-extracted with dichloromethane, butanol, and water. Three suppressive compounds were isolated by SiO2 column chromatography from dichloromethane fraction and identified as tanshinone IIA (1), tanshinone I (2) and Cryptotanshinone (3) by GC, GC-MS, 1H- and 13C-NMR spectroscopy. Compounds 1, 2 and 3 inhibited the SOS-inducing activity of Trp-P-1 in the umu test. Gene expression was suppressed by 76%, 96% and 81% at less than 0.18 μmol / mL, 9 respectively. The ID50 (50% inhibition dose) values were 0.03 μmol / mL 0.008 μmol / mL and 0.010 μmol / mol, respectively. These compounds were assayed with activated Trp-P-1. Compound 2 showed suppressive effect of SOS-inducing activity of activated Trp-P-1 but compounds 1 and 3 did not.
Export Options
About this article
Cite this article as:
Okuno Yoshiharu and Miyazawa Mitsuo, Suppressive Components in Salvia miltiorrhiza Against Trp-P-1 and Activated Trp-P-1-Induced SOS Response Using Salmonella typhimurium TA1535 / pSK1002 Umu Test, Letters in Drug Design & Discovery 2004; 1 (1) . https://dx.doi.org/10.2174/1570180043485635
DOI https://dx.doi.org/10.2174/1570180043485635 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Achieving Secure, Flexible, Effective and Privacy Preserving Data Access Control in Cloud Computing
Recent Patents on Computer Science Adiponectin: A Key Player in Obesity Related Disorders
Current Pharmaceutical Design The Flavonoid Components of <i>Scutellaria baicalensis</i>: Biopharmaceutical Properties and their Improvement using Nanoformulation Techniques
Current Topics in Medicinal Chemistry Brain Tumor Detection and Classification by Hybrid CNN-DWA Model Using MR Images
Current Medical Imaging Deciphering Dual Antiplatelet Therapy in the Era of Drug-Eluting Coronary Stents
Current Drug Targets Nocturnal Hypertension and Chronic Kidney Disease
Current Hypertension Reviews Cytokines and Chemokines as Regulators of Angiogenesis in Health and Disease
Current Pharmaceutical Design Migraine: Current Therapeutic Targets and Future Avenues
Current Vascular Pharmacology Do Statins Beneficially or Adversely Affect Glucose Homeostasis?
Current Vascular Pharmacology A Systematic Approach to Assess the Burden of Drug Interactions in Adult Kidney Transplant Patients
Current Drug Safety Have We New Therapeutic Strategies in the Treatment of Renovascular Nephropathy?
Current Vascular Pharmacology Resistance to Imatinib in Chronic Myeloid Leukemia and Therapeutic Approaches to Circumvent the Problem
Cardiovascular & Hematological Disorders-Drug Targets Depressed Serum 25-Hydroxyvitamin D Levels Increase Hospital Stay and Alter Glucose Homeostasis in First-ever Ischemic Stroke
Current Neurovascular Research Antiobesity Effect of Biochanin-A: Effect on Trace Element Metabolism in High Fat Diet-Induced Obesity in Rats
Cardiovascular & Hematological Agents in Medicinal Chemistry Mediterranean Diet Polyphenols: Anthocyanins and Their Implications for Health
Mini-Reviews in Medicinal Chemistry A Review of Neuroprotective Agents
Current Medicinal Chemistry Patent Selections
Recent Patents on Cardiovascular Drug Discovery Update on Fondaparinux: Role in Management of Thromboembolic and Acute Coronary Events
Cardiovascular & Hematological Agents in Medicinal Chemistry Multigate Quality Doppler Profiles and Morphological/Hemodynamic Alterations in Multiple Sclerosis Patients
Current Neurovascular Research Antiepileptic Drugs in the Neurosurgical Intensive Care
Current Pharmaceutical Design